Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
HIV Infections
Interventions
BEHAVIORAL

Adherence counseling

Three adherence counseling sessions will be given to participants in the trial. Two sessions will occur prior to initiation of antiretroviral medications and one session will be given one month after drug administration.

DEVICE

Alarm device

This pocket alarm device will be set to ring at designated times during the day that the participant should take their antiretroviral medication.

Trial Locations (1)

Unknown

Hope Center for Infectious Diseases, Nairobi

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Washington

OTHER

NCT00273780 - Highly Active Antiretroviral Therapy (HAART) Adherence Interventions | Biotech Hunter | Biotech Hunter